Form 483

Navinta LLC Form 483, 2017-08-18

FDA issued a Form 483 to Navinta LLC on 2017-08-18 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

Navinta LLC · Ewing, United States · Issued August 18, 2017

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

18 Aug 2017
21 CFR 314.80(j)

Failure to maintain records

Cited by Michael Serrano

18 Aug 2017
21 CFR 314.80(c)(1)(i)

Late submission of 15-day report

Cited by Michael Serrano

18 Aug 2017
21 CFR 314.80(c)(2)(ii)(A)

Incomplete periodic safety report

Cited by Michael Serrano

18 Aug 2017
21 CFR 314.80(c)(2)(ii)(B)

Late submission of an ICSR

Cited by Michael Serrano

Inspected site

NLNavinta LLCEwing, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 314.80(c)(1)(i)Cited across public-safe Form 483 observations1x
21 CFR 314.80(c)(2)(ii)(A)Cited across public-safe Form 483 observations1x
21 CFR 314.80(c)(2)(ii)(B)Cited across public-safe Form 483 observations1x
21 CFR 314.80(j)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere